Similar articles

• Investigations related to the development of a leprosy vaccine.

  Convit J, Aranzazu N, Ulrich M, Zúñiga M, de Aragón ME, Alvarado J, Reyes O. Convit J, et al. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):531-9. Int J Lepr Other Mycobact Dis. 1983. PMID: 6231259 No abstract available.
• A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.

  Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J. Rada E, et al. Int J Lepr Other Mycobact Dis. 1994 Dec;62(4):552-8. Int J Lepr Other Mycobact Dis. 1994. PMID: 7868953
• Research in leprosy. A report of a committee set up by the medical research council to study future prospects.

  [No authors listed] [No authors listed] Clin Exp Immunol. 1979 Apr;36(1):1-7. Clin Exp Immunol. 1979. PMID: 380853 Free PMC article.
• Monoclonal antibodies and recombinant DNA technology: present and future uses in leprosy and tuberculosis.

  Seckl MJ. Seckl MJ. Int J Lepr Other Mycobact Dis. 1985 Dec;53(4):618-40. Int J Lepr Other Mycobact Dis. 1985. PMID: 3910750 Review. No abstract available.
• An update on the diagnosis and treatment of leprosy.

  Moschella SL. Moschella SL. J Am Acad Dermatol. 2004 Sep;51(3):417-26. doi: 10.1016/j.jaad.2003.11.072. J Am Acad Dermatol. 2004. PMID: 15337986 Review. No abstract available.